Indeed, variants and dysregulation of ERAP1 and ERAP2 have been strongly implicated in several pathological settings such as autoimmune diseases, cancer, infections, and inflammatory conditions, as summarized in Figure 1. The gene discussed is ERAP2; the disease is cancer.